Your browser doesn't support javascript.
loading
Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19.
Li, Xue-Ting; Zhang, Mi-Wen; Zhang, Zhen-Zhou; Cao, Yu-Dan; Liu, Xiao-Yan; Miao, Ran; Xu, Yuan; Song, Xiao-Fang; Song, Jia-Wei; Liu, Ying; Xu, Ying-Le; Li, Jing; Dong, Ying; Zhong, Jiu-Chang.
Afiliación
  • Li XT; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Zhang MW; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Zhang ZZ; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; State Key Laboratory of Medical Genomics & Shanghai Instit
  • Cao YD; Department of endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Liu XY; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Miao R; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Xu Y; Department of endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Song XF; Department of endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Song JW; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Liu Y; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Xu YL; State Key Laboratory of Medical Genomics & Shanghai Institute of Hypertension, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.
  • Li J; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Dong Y; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Zhong JC; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; State Key Laboratory of Medical Genomics & Shanghai Instit
Int J Cardiol ; 336: 123-129, 2021 08 01.
Article en En | MEDLINE | ID: mdl-34000358
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Int J Cardiol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Int J Cardiol Año: 2021 Tipo del documento: Article País de afiliación: China